Pharmaceuticals

Anticoagulants Market in the US 2016-2020

  • TEC574310
  • 89 Pages
  • May 2016
  • Pharmaceuticals
About the Anti-Coagulant Drugs Market
Anticoagulants have been used for over 80 years to treat clotting disorders. It is used as a first line of defense for disorders such as deep vein thrombosis (DVT), pulmonary embolism, AF, and acute coronary syndrome. With the advent of time, traditional therapies are replaced by novel oral anticoagulants, which have better safety and efficacy profiles.

The 1990s saw rapid development in the field of direct thrombin inhibitors. Though these drugs, such as hirudin, have been in use from the early 19th century, they were accepted with the development of genetic engineering technology. The recombinant forms, such as desirudin, are also available in the market. During the same period, the focus shifted toward the development of factor Xa inhibitors, and by early 2000s, the first indirect factor Xa inhibitor, fondaparinux, was released into the market. These drugs were administered by parenteral route.

Technavios analysts forecast the anti-coagulants market in the US to grow at a CAGR of 6.67% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the anti-coagulants market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generics drugs used to treat coagulation disorders. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market.

Technavio's report, Anti-Coagulants Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Johnson & Johnson
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Daiichi Sankyo

Other prominent vendors
Armatheon Inc.
Aspen
AstraZeneca
Bayer
Cellceutix
Cosmo Pharmaceuticals SA
CSL Behring, Eisai, GSK
Marathon Pharmaceuticals LLC
Ockham Biotech
Perosphere
Portola Pharmaceuticals
Sagent Pharmaceuticals Inc.
The Medicines Company
Urigen Pharmaceuticals Inc.
Valeant Pharmaceuticals

Market driver
Growing prevalence of coagulation disorders
For a full, detailed list, view our report

Market challenge
Side-effects associated with drugs
For a full, detailed list, view our report

Market trend
Expected exploitation of new therapeutic use
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Hormone Refractory Breast Cancer Asia-Pacific Market Research Report, 2013 - 2020

Breast cancer is the most common type of malignant cancer prevalent in women above the age of 40. According to the estimates of World Health Organization, cancer is the most ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Histone Deacetylase Inhibitors Market - Analysis, Growth, Global Share, Industry Overview, Trends Opportunities and Forecast 2012 - 2020

Increasing cancer incidences, ongoing research and development on HDAC inhibitors for the treatment of cancer and other diseases, and the potential of HDAC inhibitors to improve the effectiveness of new ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Meningococcal Vaccines Market (Types and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Meningococcal vaccines are used to treat meningitis caused by bacterium N. meningitidis. Previously there were no precautionary measures available to avoid meningitis. Antibiotics along with nutrient supplements were used to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Dialysis Market (Types, Products and Services, End-users and Geography)Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Dialysis is the process of removing excess water and waste from the blood by artificial means, primarily in cases of renal failure. It is also used for patients with acute ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

July 2017  |   Price:$ 4995    | Pre Book Price:$ 4995

Read More >>

Global Human Insulin Market (Product Type, Brand and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>